12 Results for "

germinal center B cells

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "germinal center B cells" in MCE Product Catalog:

Cat. No.: HY-12291
CAS No.: 1315329-43-1
Purity:  99.69%
Synonyms: HMSL 10017-101-1
Target:  

Raf Apoptosis

Research Areas:  

Cancer

HG6-64-1 (HMSL 10017-101-1) is a B-raf kinase modulator.HG6-64-1 modulates B-raf kinase activity, including the V600E mutant form and the drug-resistant gatekeeper mutation T529I. HG6-64-1 is a germinal center kinase inhibitor. HG6-64-1 induces cell cycle arrest and apoptosis. HG6-64-1 can be used for the research of diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-139664A
CAS No.: 2170140-50-6
Purity:  98.97%
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032 (HY-139664) and is a potent, non-covalent, reversible DNMT1-selective inhibitor with an IC50 of 0.036 μM against DNMT1. (R)-GSK-3685032 preferentially binds DNMT1 in a hemimethylated DNA context, inhibits DNA methylation maintenance by occupying the DNMT1 active site loop that inserts into DNA and by interacting with the target recognition domain, thereby inducing DNA hypomethylation and transcriptional activation. (R)-GSK-3685032 is useful for research on DNMT1, acute myeloid leukemia, and B cell humoral immunity .
loading...
    loading...
Cat. No.: HY-148631
CAS No.: 2728727-91-9
Target:  

BCL6

Research Areas:  

Inflammation/Immunology Cancer

GSK137 is an orally active, potent and selective B-cell lymphoma 6 (BCL6) inhibitor. GSK137 blocks the interaction between BCL6 and corepressors (e.g., SMRT), reducing the number of germinal center B cells. GSK137 is promising for research of autoimmune diseases such as systemic lupus erythematosus (SLE) and B-cell-related tumors such as diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-174738
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human CD40 mRNA encodes the human CD40 molecule (CD40) protein, a member of the TNF-receptor superfamily. CD40 is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation.
loading...
    loading...
Cat. No.: HY-162754
CAS No.: 3053755-09-9
Target:  

Proteasome

Research Areas:  

Inflammation/Immunology

LMP7/LMP2-IN-1 (Compound 19) is the orally active inhibitor for immunoproteasome subunits LMP7 and LMP2 with IC50 of 257 and 10 nM. LMP7/LMP2-IN-1 reduces the generation of antibody, downregulates the cells in spleen germinal center B and in plasma in NP-OVA-immunized mice, and can be used in research about autoimmune diseases .
loading...
    loading...
Cat. No.: HY-158813
CAS No.: 2364639-42-7
Research Areas:  

Cancer

S-Geranylgeranyl-L-glutathione is a P2RY8 inhibitor and intercellular signaling molecule that exists endogenously in human bone marrow interstitial fluid. S-Geranylgeranyl-L-glutathione promotes the internalization of P2RY8 and antagonizes chemokine-induced activation of pAkt. S-Geranylgeranyl-L-glutathione negatively regulates the migration of B cells and T cells to the bone marrow, inhibits chemokine-mediated migration of germinal center B cells and follicular helper T cells, participates in lymphocyte guidance regulation, and modulates the germinal center response process. S-Geranylgeranyl-L-glutathione can be used in research related to diffuse large B-cell lymphoma and Burkitt lymphoma .
loading...
    loading...
Cat. No.: HY-162268
CAS No.: 3032823-58-5
Target:  

MALT1 Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

MALT1-IN-13 (compound 10m) is inhibitor for mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), which to binds MALT1 protease covalently and irreversibly, inhibits MALT1 with the IC50 of 1.7 μM. MALT1-IN-13 inhibits proliferation against ABC-DLBCL and induces apoptosis in ABC-DLBCL HBL1. MALT1-IN-13 regulates mTOR and PI3K-Akt pathways .
loading...
    loading...
Cat. No.: HY-151394
CAS No.: 3051788-72-5
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-33 is an inhibitor of [1,2]oxazoloisoindoles tubulin polymerization, exhibits high antiproliferative activity against the NCI panel .
loading...
    loading...
Cat. No.: HY-151395
CAS No.: 3051788-87-2
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-34 is an inhibitor of [1,2]oxazoloisoindoles tubulin polymerization, demonstrates high selectivity against marginal zone lymphoma VL51 cell line .
loading...
    loading...
Cat. No.: HY-151396
CAS No.: 3051788-88-3
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-35 is an inhibitor of [1,2]oxazoloisoindoles tubulin polymerization, demonstrates high selectivity against marginal zone lymphoma VL51 cell line .
loading...
    loading...
Cat. No.: HY-148640
CAS No.: 2253985-29-2
Research Areas:  

Cancer

WK500B is a potent and orally active BCL6 inhibitor with a KD of 1.61 μM. WK500B engages intracellular BCL6 and disrupts BCL6‑corepressor interactions to reactivate BCL6 target genes. WK500B exerts cytotoxicity against diffuse large Bcell lymphoma cells and induces apoptosis and cell cycle arrest. WK500B suppresses germinal center formation in C57BL/6 mice and DLBCL tumor growth in SCID xenograft models without observable toxicity. WK500B can be used for the study of diffuse large Bcell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-182706
CAS No.: 95455-02-0
Research Areas:  

Cancer

NSC 373981 is a CARD11 G4 stabilizer. NSC 373981 stabilizes the CARD11 G4 structure and inhibits CARD11 transcription in cells. NSC 373981 also inhibits BCL2 and MYC. NSC 373981 suppresses the transcription of KRAS and TERT. NSC 373981 exhibits anticancer activity against diffuse large B-cell lymphoma .
loading...
    loading...
  • 1